ESAC vs. QOMO, NOVV, ADRT, CETU, YOTA, AIB, DHAC, PLTN, WAVS, and KACL
Should you be buying ESGEN Acquisition stock or one of its competitors? The main competitors of ESGEN Acquisition include Qomolangma Acquisition (QOMO), Nova Vision Acquisition (NOVV), Ault Disruptive Technologies (ADRT), Cetus Capital Acquisition (CETU), Yotta Acquisition (YOTA), AIB Acquisition (AIB), Digital Health Acquisition (DHAC), Plutonian Acquisition (PLTN), Western Acquisition Ventures (WAVS), and Kairous Acquisition (KACL). These companies are all part of the "holding & other investment offices" industry.
ESGEN Acquisition (NASDAQ:ESAC) and Qomolangma Acquisition (NASDAQ:QOMO) are both small-cap unclassified companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, community ranking, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.
26.2% of ESGEN Acquisition shares are owned by institutional investors. Comparatively, 21.6% of Qomolangma Acquisition shares are owned by institutional investors. 4.2% of ESGEN Acquisition shares are owned by company insiders. Comparatively, 1.1% of Qomolangma Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
ESGEN Acquisition has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Comparatively, Qomolangma Acquisition has a beta of 0.04, suggesting that its share price is 96% less volatile than the S&P 500.
In the previous week, ESGEN Acquisition had 1 more articles in the media than Qomolangma Acquisition. MarketBeat recorded 1 mentions for ESGEN Acquisition and 0 mentions for Qomolangma Acquisition. ESGEN Acquisition's average media sentiment score of 0.00 equaled Qomolangma Acquisition'saverage media sentiment score.
ESGEN Acquisition and Qomolangma Acquisition both received 0 outperform votes by MarketBeat users.
Summary
ESGEN Acquisition beats Qomolangma Acquisition on 3 of the 4 factors compared between the two stocks.
Get ESGEN Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for ESAC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ESGEN Acquisition Competitors List
Related Companies and Tools
